In Vitro Activity of a Novel Diaminopyrimidine Compound, Iclaprim, against Chlamydia trachomatis and C. pneumoniae

The in vitro activities of iclaprim, a novel dihydrofolate reductase inhibitor, azithromycin, and levofloxacin were tested against 10 strains of Chlamydia trachomatis and 10 isolates of Chlamydia pneumoniae. For C. trachomatis and C. pneumoniae, the iclaprim MIC and minimal bactericidal concentratio...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kohlhoff, S. A., Roblin, P. M., Reznik, T., Hawser, S., Islam, K., Hammerschlag, M. R.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2004
Témata:
Susceptibility
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC400585/
https://ncbi.nlm.nih.gov/pubmed/15105151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.5.1885-1886.2004
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky